Next Article in Journal
Matrix Metalloproteinases: The Gene Expression Signatures of Head and Neck Cancer Progression
Next Article in Special Issue
Genetic Interactions of STAT3 and Anticancer Drug Development
Previous Article in Journal
The Role of Matrix Metalloproteinases in Colorectal Cancer
Previous Article in Special Issue
Loss of STAT3 in Lymphoma Relaxes NK Cell-Mediated Tumor Surveillance
Cancers 2014, 6(1), 376-395; doi:10.3390/cancers6010376

STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications

 and *
Received: 16 December 2013 / Revised: 19 January 2014 / Accepted: 29 January 2014 / Published: 10 February 2014
(This article belongs to the Special Issue STAT3 Signalling in Cancer: Friend or Foe)
View Full-Text   |   Download PDF [398 KB, uploaded 10 February 2014]   |   Browse Figure
Abstract: Signal transducer and activator of transcription 3 (STAT3) is a potent regulator of gliomagenesis through its induction of angiogenesis, host immunosuppression, and tumor invasion. Gain of function mutations result in constitutive activation of STAT3 in glioma cells, making STAT3 an attractive target for inhibition in cancer therapy. Nevertheless, some studies show that STAT3 also participates in terminal differentiation and apoptosis of various cell lines and in glioma with phosphatase and tensin homolog (PTEN)-deficient genetic backgrounds. In light of these findings, the utility of STAT3 as a prognostic indicator and as a target of drug therapies will be contingent on a more nuanced understanding of its pro- and anti-tumorigenic effects.
Keywords: glioblastoma; STAT3; immunotherapy glioblastoma; STAT3; immunotherapy
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Kim, J.E.; Patel, M.; Ruzevick, J.; Jackson, C.M.; Lim, M. STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications. Cancers 2014, 6, 376-395.

AMA Style

Kim JE, Patel M, Ruzevick J, Jackson CM, Lim M. STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications. Cancers. 2014; 6(1):376-395.

Chicago/Turabian Style

Kim, Jennifer E.; Patel, Mira; Ruzevick, Jacob; Jackson, Christopher M.; Lim, Michael. 2014. "STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications." Cancers 6, no. 1: 376-395.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert